AbbVie's Duopa successor in Parkinson's rejected again after FDA flags third-party manufacturer issues

AbbVie's Duopa successor in Parkinson's rejected again after FDA flags third-party manufacturer issues fkansteiner Tue, 06/25/2024 - 09:39